Alzamend Neuro Advances Lithium Imaging Research
ATLANTA, August 18, 2026 Alzamend Neuro, Inc. announced that pharmacokinetic imaging data from its Phase 1/2A clinical trial of...
cartilage repair
Advertisement
FibroBiologics Advances Cartilage Repair With Cell Therapy
HOUSTON, August 18, 2026 FibroBiologics, Inc., a clinical-stage biotechnology company developing therapies based on fibroblast cells and fibroblast-derived materials,...
Regentis Wins European Approval for New GelrinC Process
HERZLIYA, Israel, July 15, 2026 Regentis Biomaterials announced that it has received approval from the European Notified Body for...
Regentis Develops Solvent-Free GelrinC Process Boost
HERZLIYA, Israel, March 17, 2026 Regentis Biomaterials Ltd. has announced a breakthrough solvent-free manufacturing process for its lead regenerative...
Regentis Expands Phase III GelrinC Trial Across U.S. Sites
HERZLIYA, Israel, January 29, 2026 — Regentis Biomaterials Ltd. announced a significant expansion of its U.S. clinical site network...
Advertisements
OvertureTi Knee System Reaches $1M Sales Milestone
Irvine, California | December 30, 2025 — Overture Orthopaedics, a U.S.-based medical device company specializing in joint preservation technologies,...
Advertisement
